SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Eric Linsley to join panel at the MedTech Investing Conference in Minneapolis, MN
News | 05. 10. 2006
